Catalyst Event
Pfizer Inc (PFE) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
5/13/2026, 12:00:00 AM
The European Commission granted marketing authorization for HYMPAVZI (marstacimab) on 2026-05-13 for the treatment of adults and adolescents with hemophilia A or B with inhibitors (Low importance as a standard regulatory approval).
Korean Translation
2026년 5월 13일, 유럽연합 집행위원회는 억제인자를 보유한 혈우병 A 또는 B 성인 및 청소년 환자 치료를 위한 힘파브지(HYMPAVZI, marstacimab)의 판매를 승인함(통상적인 규제 승인에 따른 낮은 영향 예상).
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM